The firm's financial position is deteriorating, with total assets contracting from $179.7M in 2023Q4 to $137.6M in 2026Q1, while retained earnings have eroded to $9.6M over the same period.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 |
|---|
| Total Current Assets | 59.96M | 63.08M | 73.27M | 77.65M | 88.81M | 104.51M | 69.48M | 28.41M | 23.85M | 26.61M | 26.68M | 30.81M | 34.23M | 37.91M | 35.44M | 35.75M | 40.22M | 39.26M | 43.61M | 51.92M | 57.78M | 61.49M | 65.05M | 13.5M | 7.07M | 6.27M | 8.06M |
| Cash & Short-Term Investments | 35.62M | 36.97M | 44.56M | 47.29M | 49.38M | 42.43M | 25.65M | 13.71M | 10.64M | 14.88M | 16.2M | 18.05M | 22.13M | 27.63M | 25.96M | 25.67M | 23.27M | 18.13M | 33.28M | 40.51M | 46.81M | 52.51M | 55.87M | 8.16M | 1.34M | 1.22M | 3.73M |
| Cash Only | 2.77M | 2.59M | 4.24M | 12.67M | 19.72M | 29.16M | 17.57M | 5.93M | 9.65M | 14.88M | 16.2M | 18.05M | 22.13M | 27.63M | 25.96M | 25.67M | 23.27M | 18.13M | 33.28M | 40.51M | 46.81M | 52.51M | 55.87M | 8.16M | 1.34M | 1.22M | 3.73M |
| Short-Term Investments | 32.85M | 34.38M | 40.33M | 34.62M | 29.66M | 13.27M | 8.08M | 7.77M | 996.23K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 7.29M | 8.21M | 8.77M | 11.83M | 17.48M | 40.78M | 32.91M | 6.61M | 5.01M | 5.11M | 3.27M | 4.9M | 5.64M | 3.48M | 3.7M | 3.62M | 7.59M | 13.6M | 3.29M | 4.01M | 4.31M | 3.97M | 3.21M | 1.17M | 2.67M | 1.59M | 2.33M |
| Days Sales Outstanding | 81.91 | 78.33 | 96.81 | 99.02 | 67.29 | 79.02 | 146.74 | 57.76 | 54.99 | 54.02 | 39.99 | 60.53 | 59.66 | 41.22 | 40.18 | 41.11 | 76.53 | 127.38 | 43.03 | 55.71 | 62.16 | 59.73 | 54.5 | 22.39 | 47.91 | 35.83 | 88.03 |
| Inventory | 16.43M | 17.19M | 19.19M | 17.58M | 20.68M | 20.59M | 10.23M | 7.45M | 7.55M | 6.21M | 7.02M | 6.3M | 4.66M | 5.74M | 4.99M | 6.24M | 8.68M | 6.91M | 6.64M | 7.04M | 6.39M | 3.3M | 3.78M | 3.98M | 2.78M | 3.22M | 1.58M |
| Days Inventory Outstanding | 183.26 | 164.15 | 205.54 | 186.06 | 113.42 | 80.78 | 83.28 | 98.32 | 119.46 | 92.38 | 131.45 | 121.04 | 75.66 | 102.25 | 81.07 | 107.39 | 133.07 | 99 | 123.22 | 140.36 | 131.1 | 78.02 | 84.05 | 99.05 | 67.68 | 88.18 | 73.01 |
| Other Current Assets | 622.43K | 711.27K | 753.06K | 952.67K | 1.26M | 701.97K | 684.32K | 635.2K | 644.8K | 418.15K | 192.55K | 1.57M | 1.79M | 1.07M | 783.76K | 218.53K | 681.24K | 624.39K | 400.11K | 358.81K | 267.71K | 1.71M | 2.18M | 194.31K | 276.52K | 245.56K | 426.76K |
| Total Non-Current Assets | 77.64M | 79.55M | 87.45M | 102.02M | 121.93M | 108.65M | 35.49M | 17.43M | 12.95M | 11.55M | 12.1M | 11.73M | 11.12M | 11.19M | 12.19M | 13.02M | 12.97M | 14.68M | 14.92M | 12.41M | 13.01M | 12.27M | 11.45M | 10.13M | 10.99M | 12.27M | 12.43M |
| Property, Plant & Equipment | 77.31M | 79.18M | 87.35M | 93.48M | 100.15M | 87.93M | 30.82M | 10.71M | 10.85M | 11.35M | 12.09M | 11.47M | 10.85M | 10.91M | 11.9M | 12.65M | 12.56M | 14.23M | 14.44M | 11.48M | 12.21M | 11.93M | 11.06M | 9.68M | 10.52M | 11.74M | 11.9M |
| Fixed Asset Turnover | 0.46x | 0.48x | 0.38x | 0.47x | 0.95x | 2.14x | 2.66x | 3.90x | 3.07x | 3.04x | 2.47x | 2.58x | 3.18x | 2.82x | 2.83x | 2.54x | 2.88x | 2.74x | 1.93x | 2.29x | 2.07x | 2.03x | 1.95x | 1.97x | 1.93x | 1.38x | 0.81x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 257.18K | 265.77K | 275.04K | 286.52K | 362.98K | 406.91K | 426.68K | 470.12K | 424.56K | 279.85K | 316.93K | 358.66K | 394.37K | 405.64K | 530.38K | 529.8K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50.39K | 1.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.25B | -1.89M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 330.94K | 366.91K | 103.63K | 152.06K | 184.52K | 5.67K | 44.57K | 5.96K | 103.68K | 194.51K | 10.29K | 4.92K | 4.92K | 4.92K | 4.92K | 0 | 0 | 18.75K | 18.75K | 505.9K | 522.29K | 27.33K | 34.01K | 60.56K | 72.67K | 0 | 0 |
| Total Assets | 137.6M | 142.63M | 160.72M | 179.67M | 210.74M | 213.15M | 104.97M | 45.84M | 36.79M | 38.16M | 38.78M | 42.54M | 45.35M | 49.1M | 47.63M | 48.76M | 53.19M | 53.94M | 58.54M | 64.33M | 70.79M | 73.76M | 76.49M | 23.63M | 18.06M | 18.54M | 20.49M |
| Asset Turnover | 0.26x | 0.27x | 0.21x | 0.24x | 0.45x | 0.88x | 0.78x | 0.91x | 0.90x | 0.90x | 0.77x | 0.69x | 0.76x | 0.63x | 0.71x | 0.66x | 0.68x | 0.72x | 0.48x | 0.41x | 0.36x | 0.33x | 0.28x | 0.81x | 1.13x | 0.87x | 0.47x |
| Asset Growth % | -34.8% | -11.26% | -10.55% | -14.74% | -1.13% | 103.06% | 129.02% | 24.58% | -3.57% | -1.61% | -8.84% | -6.2% | -7.63% | 3.08% | -2.32% | -8.33% | -1.39% | -7.85% | -9% | -9.13% | -4.01% | -3.58% | 223.71% | 30.85% | -2.6% | -9.51% | - |
| Total Current Liabilities | 10.45M | 9.6M | 8.78M | 9.38M | 12.14M | 35.32M | 27.9M | 8.26M | 8.54M | 7.9M | 7.17M | 8.1M | 15.1M | 16.62M | 8.08M | 5.97M | 9.99M | 13.2M | 10.24M | 8.79M | 6.89M | 5.46M | 7.85M | 5.77M | 8.02M | 8.8M | 5.94M |
| Accounts Payable | 5.38M | 5.34M | 4.29M | 4.78M | 6.4M | 20.4M | 16.26M | 5.01M | 5.37M | 4.96M | 4.47M | 5.7M | 5.14M | 5.11M | 5.1M | 3.66M | 3.85M | 7M | 6.14M | 5.54M | 4.25M | 2.35M | 3.4M | 3.76M | 4.23M | 3.92M | 1.87M |
| Days Payables Outstanding | 47.65 | 51 | 45.96 | 50.58 | 35.12 | 80.06 | 132.29 | 66.08 | 85.02 | 73.79 | 83.77 | 109.53 | 83.43 | 91.05 | 82.85 | 62.99 | 58.98 | 100.29 | 114 | 110.4 | 87.21 | 55.49 | 75.67 | 93.53 | 102.98 | 107.33 | 86.57 |
| Short-Term Debt | 481.93K | 365.28K | 332.48K | 303.99K | 1.38M | 1.39M | 1.03M | 343.3K | 406.36K | 410.95K | 430.39K | 249.35K | 149.74K | 247.06K | 315.09K | 620.47K | 519.61K | 2.63M | 451.87K | 387.91K | 261.9K | 295.42K | 271.84K | 210.68K | 840.9K | 686.4K | 971.68K |
| Deferred Revenue (Current) | 2.37M | 352.64K | 376.56K | 201.49K | 435.92K | 2.34M | 1.69M | 998.6K | 860.93K | 355.74K | 692.92K | 395.4K | 435.82K | 1.72M | 1.4M | 780.5K | 0 | 0 | 0 | 1.44M | 961.28K | 0 | 945.71K | 1.54M | 1.08M | 1.68M | 1.16M |
| Other Current Liabilities | 3.26M | 762.21K | 1.07M | 865.11K | 2.85M | 5.18M | 826.76K | 1.28M | 540.85K | 1.62M | 1.72M | 1.38M | 9.09M | 10.19M | 1.59M | 1.03M | 4.86M | 3.01M | 2.99M | 2.3M | 1.86M | 2.43M | 2.04M | 265.47K | 1.87M | 2.52M | 1.94M |
| Current Ratio | 5.74x | 6.57x | 8.34x | 8.28x | 7.32x | 2.96x | 2.49x | 3.44x | 2.79x | 3.37x | 3.72x | 3.81x | 2.27x | 2.28x | 4.39x | 5.99x | 4.03x | 2.98x | 4.26x | 5.91x | 8.39x | 11.26x | 8.28x | 2.34x | 0.88x | 0.71x | 1.36x |
| Quick Ratio | 4.17x | 4.78x | 6.16x | 6.41x | 5.61x | 2.38x | 2.12x | 2.54x | 1.91x | 2.58x | 2.74x | 3.03x | 1.96x | 1.94x | 3.77x | 4.94x | 3.16x | 2.45x | 3.61x | 5.11x | 7.46x | 10.66x | 7.80x | 1.65x | 0.53x | 0.35x | 1.09x |
| Cash Conversion Cycle | 217.53 | 191.49 | 256.39 | 234.5 | 145.59 | 79.75 | 97.74 | 90 | 89.44 | 72.61 | 87.67 | 72.05 | 51.88 | 52.41 | 38.4 | 85.51 | 150.62 | 126.09 | 52.25 | 85.66 | 106.05 | 82.26 | 62.89 | 27.9 | 12.61 | 16.69 | 74.46 |
| Total Non-Current Liabilities | 57.06M | 58.66M | 64.77M | 71.01M | 92.07M | 78.66M | 27.19M | 9.04M | 2.64M | 3.08M | 3.5M | 3.42M | 3.43M | 3.58M | 3.83M | 4.14M | 4.3M | 4.82M | 6.1M | 3.78M | 4.19M | 5.06M | 4.98M | 2.72M | 2.6M | 9.58M | 7.18M |
| Long-Term Debt | 434.12K | 530.37K | 900.04K | 1.23M | 1.53M | 2.85M | 2.71M | 2.38M | 2.64M | 3.08M | 3.5M | 3.42M | 3.43M | 3.58M | 3.83M | 4.14M | 4.3M | 4.82M | 6.1M | 3.75M | 4.14M | 4.35M | 3.54M | 2.72M | 2.6M | 9.58M | 7.18M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 15.08M | 6.85M | 2.19M | 6.66M | 7.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36.2K | 45.7M | 711.44M | 1.44M | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 56.62M | 58.13M | 63.87M | 69.77M | 75.46M | 68.96M | 24.48M | 0 | 82.36K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 67.5M | 68.26M | 73.55M | 80.38M | 104.21M | 113.98M | 55.09M | 17.29M | 11.18M | 10.98M | 10.67M | 11.51M | 18.52M | 20.2M | 11.9M | 10.11M | 14.29M | 18.02M | 16.33M | 12.57M | 11.08M | 10.52M | 12.83M | 8.5M | 10.62M | 18.38M | 13.12M |
| Total Debt | 916.05K | 895.64K | 1.23M | 1.54M | 2.92M | 4.24M | 3.74M | 2.72M | 3.05M | 3.49M | 3.93M | 3.67M | 3.57M | 3.82M | 4.14M | 4.76M | 4.82M | 7.45M | 6.55M | 4.14M | 4.4M | 4.65M | 3.81M | 2.93M | 3.44M | 10.27M | 8.15M |
| Net Debt | -1.85M | -1.69M | -3M | -11.13M | -16.8M | -24.92M | -13.83M | -3.21M | -6.6M | -11.39M | -12.27M | -14.38M | -18.55M | -23.81M | -21.82M | -20.91M | -18.44M | -10.67M | -26.74M | -36.37M | -42.42M | -47.87M | -52.06M | -5.22M | 2.1M | 9.05M | 4.42M |
| Debt / Equity | 0.01x | 0.01x | 0.01x | 0.02x | 0.03x | 0.04x | 0.08x | 0.10x | 0.12x | 0.13x | 0.14x | 0.12x | 0.13x | 0.13x | 0.12x | 0.12x | 0.12x | 0.21x | 0.16x | 0.08x | 0.07x | 0.07x | 0.06x | 0.19x | 0.46x | 63.12x | 1.11x |
| Debt / EBITDA | -0.06x | - | - | - | 0.78x | 0.06x | 0.15x | 0.71x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 0.12x | - | - | - | -4.48x | -0.34x | -0.56x | -0.84x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -96.15x | -230.03x | -27.74x | -57.60x | 31.25x | 330.91x | 101.18x | 19.91x | -6.64x | -17.62x | -16.32x | 20.68x | -9.53x | -25.55x | -16.83x | 6.96x | 8.35x | -604.70x | -176.41x | -30.48x | -16.33x | -8.47x | -32.79x | -19.22x | -13.23x | -12.13x | -46.65x |
| Total Equity | 70.09M | 74.38M | 87.17M | 99.29M | 106.54M | 99.17M | 49.88M | 28.54M | 25.61M | 27.17M | 28.11M | 31.03M | 26.83M | 28.9M | 35.73M | 38.65M | 38.9M | 35.92M | 42.21M | 51.76M | 59.71M | 63.24M | 63.66M | 15.13M | 7.44M | 162.62K | 7.37M |
| Equity Growth % | -41.69% | -14.68% | -12.2% | -6.8% | 7.43% | 98.82% | 74.76% | 11.43% | -5.74% | -3.32% | -9.41% | 15.65% | -7.17% | -19.11% | -7.56% | -0.64% | 8.3% | -14.89% | -18.46% | -13.31% | -5.57% | -0.67% | 320.65% | 103.5% | 4473.23% | -97.79% | - |
| Book Value per Share | 2.34 | 2.48 | 2.91 | 3.32 | 3.23 | 2.90 | 1.50 | 0.87 | 0.78 | 0.85 | 0.96 | 1.05 | 0.98 | 1.07 | 1.36 | 1.47 | 1.48 | 1.51 | 1.77 | 2.18 | 2.53 | 2.71 | 2.50 | 0.62 | 0.37 | 0.01 | 0.38 |
| Total Shareholders' Equity | 70.09M | 74.38M | 87.17M | 99.29M | 106.54M | 99.17M | 49.88M | 28.54M | 25.61M | 27.17M | 28.11M | 31.03M | 26.83M | 28.9M | 35.73M | 38.65M | 38.9M | 35.92M | 42.21M | 51.76M | 59.71M | 63.24M | 63.66M | 15.13M | 7.44M | 162.62K | 7.37M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37.67M | 36.77M |
| Retained Earnings | 9.59M | 13.87M | 26.67M | 38.79M | 46.03M | 41.18M | -9.67M | -33.89M | -37.04M | -35.7M | -31.96M | -28.02M | -32.34M | -29.98M | -23.77M | -19.63M | -21.05M | -23.45M | -14.03M | -4.39M | 2.56M | 6.43M | 7.67M | -39.9M | -47.35M | -40.53M | -33.31M |
| Treasury Stock | -12.89M | -12.89M | -12.89M | -12.89M | -12.89M | -5.27M | 0 | 0 | 0 | 0 | 0 | 0 | -1.1M | -1.1M | -122.2K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -24.67M | -23.78M | -22.95M | -22.09M | -21.24M | -20.17M | -18.98M | -17.72M | -16.45M | -14.99M | -13.63M | -12.28M | -10.91M | -9.53M | -8.23M | -6.97M | -5.71M | -4.43M | -3.29M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liquidity and operational insolvency
As reported in recent financial filings, RVP's total assets have contracted from $179.7M in 2023Q4 to $137.6M in 2026Q1, reflecting a consistent downward trend that suggests the company is liquidating its balance sheet to fund ongoing operational losses rather than investing in future growth.
The steady decline in total assets, coupled with the erosion of retained earnings, points to a business model that is currently consuming its own capital base. Investors should monitor whether this trajectory leads to a critical breach of liquidity thresholds as the asset base continues to shrink.
Based on the provided quarterly data, net PPE accounts for approximately 56% of total assets as of 2026Q1, indicating an asset-heavy manufacturing model that lacks the flexibility to pivot away from its current high-cost, low-margin production environment in Little Elm, Texas.
The high concentration of capital in specialized manufacturing equipment may represent a significant impairment risk if the company cannot achieve the utilization rates necessary to justify these assets. This lack of asset liquidity limits the firm's ability to raise non-dilutive capital during periods of operational stress.
According to the latest balance sheet, cash and equivalents have dwindled to $2.8M as of 2026Q1, a sharp decline from the $12.7M reported in 2023Q4, which suggests the company's buffer against operational shocks is rapidly evaporating in the face of persistent negative cash flow.
While the current ratio remains elevated at 5.74, this metric is likely distorted by the composition of current assets, which may include slow-moving inventory that is difficult to convert to cash. The rapid depletion of liquid reserves warrants immediate investigation into the company's near-term funding requirements.
As indicated by historical balance sheet data, retained earnings have fallen from $38.8M in 2023Q4 to $9.6M in 2026Q1, illustrating the cumulative impact of sustained operating losses on the company's equity quality and overall financial health.
The consistent reduction in retained earnings suggests that the company is effectively returning no value to shareholders and is instead depleting its equity base to cover operating deficits. This trend may indicate that the current business model is not self-sustaining without external capital injections.
Based on the provided financial statements, the absence of significant goodwill or intangible assets is notable, yet the reliance on physical inventory in a rapidly evolving medical device market suggests a potential for hidden write-downs that could further impair the company's already fragile equity position.
Investors should be cautious of the valuation of inventory on the balance sheet, as any shift in clinical standards could render existing stock obsolete. The lack of transparency regarding inventory aging makes it difficult to assess the true realizable value of the company's current asset base.
Quick answers to the most common questions about buying RVP stock.
As of 2025, Retractable Technologies, Inc. (RVP) had total assets of $142.6M including $63.1M in current assets.
Retractable Technologies, Inc. (RVP) carries total debt of $0.9M, offset by $37.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Retractable Technologies, Inc. (RVP) has total shareholders' equity (book value) of $74.4M ($2.48 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Retractable Technologies, Inc. (RVP) reported a current ratio of 6.57x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.